Moreover, Kynurenine, produced by glioblastomas, activates the aryl hydrocarbon receptor (AHR) in macrophages, resulting in the induction of CD39 expression and enhanced adenosine production, which suppresses CD8+ T cell immunity and promotes GBM progression [41]. Here, CD8A is linked to glioblastoma.